美诺华：在手订单充足 JH389项目欧洲安全性试验正在进行中

Core Viewpoint - The company has a strong order backlog and is actively advancing its JH389 project in the medical aesthetics sector, focusing on weight loss and blood sugar control [1] Group 1: Company Developments - The JH389 project has submitted a patent application in Europe during Q3 2025 [1] - Ongoing safety trials for the JH389 project in Europe are progressing smoothly [1] - The company and its partners are concentrating on production, formulation design, and scientific research related to the JH389 project [1] Group 2: Commercialization Efforts - The company is actively promoting the commercialization of the JH389 project [1]